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Baculoviruses are a unique group of eukaryotic vi-
ruses that parasitize insects. The prototype member 
of the family Baculoviridae is Autographa californica 
multiple nuclear polyhedrosis virus (AcMNPV). 
Global interest in baculovirus biology stems from 
two important uses of baculoviruses – as biopesti-
cides and as a highly favoured eukaryotic expression 
system for the large-scale production of recombinant 
proteins in the laboratory. Of late, baculoviruses 
have invited renewed interest by virtue of their po-
tential use as a delivery system in gene th rapy. Al-
though the baculovirus expression vector system 
(BEVS) is extensively used worldwide, the transcrip-
tional regulation of the hyperactive promoters used 
to drive foreign gene expression still remains 
shrouded in mystery. It is clear, however, that this 
regulation involves an intricate interplay of both 
host and viral factors. This review provides an over-
view of what we do know about the mechanisms of 
transcription of baculoviral genes, with special em-
phasis on the polyhedrin promoter, the workhorse 
promoter of the BEVS, and the insect cell host fac-
tors involved in enhancing transcription from it. 
Baculoviruses: Versatile and effective 
biopesticides 
The natural hosts of baculoviruses are insects belonging 
mainly to the classes Lepidoptera (butterflies and 
moths), Hymenoptera (sawflies) and Coleoptera (bee-
tles). Many of these insects are plant pathogens, infect-
ing agriculturally important crops and forest trees. 
Although chemical pesticides continue to be used to 
tackle this problem, farmers and agricultural scientists 
have of late recognized the importance of developing a 
safer and more eco-friendly alternative to such harsh 
chemical insecticides. Baculoviruses present the perfect 
biological solution to curb insect pest popula ions while 
simultaneously respecting the enviromental balance. 
The viruses can be sprayed as a powder over the crops, 
whereby they are ingested by the feeding insect larvae, 
multiply in the host and ultimately kill the organism, 
releasing fresh virus particles into the environmt t  
start the cycle all over again. There are several advan-
tages of using baculoviruses as insectic des – they can 
be specifically targeted to certain pests, are self-
propagating, safe for human handling and do not pollute 
the environment, thus preventing health hazards. 
 However, for a variety of reasons, it has proved more 
difficult than expected to develop effective baculovirus 
insecticide formulations. The reason for this is mainly 
the virus’s low persistence in the environment, espe-
cially when recombinant baculoviruses are used. An-
other major drawback is the slow speed of killing in 
contrast to chemical insecticides which have a much 
more rapid knockdown effect. The widespread use of 
baculoviruses as pesticides is further hindered by their 
narrow host range, instability of insecticide formula-
tions, and problems in registration and patentability. 
However, despite these limitations, the enormous ec-
logical advantages of this approach makes the attempt 
to develop new-age and more efficient baculovirus 
biopesticides on a global scale well worth the effort1. 
The baculovirus expression vector system: A 
biofactory par excellence for the production of 
recombinant proteins 
The second – and far more important – use of baculovi-
ruses is as a vehicle for large-scal  protein production. 
Baculoviruses have been very successfully used for the 
past couple of decades, for the expression of high levels 
of recombinant proteins2,3. Hundreds of proteins have 
been expressed to date by constructing recombinant 
baculoviruses. The heterologous gene is xpressed usu-
ally under the control of the hypertranscribed polyhed-
rin (polh) or p10 gene promoters that are turned on very 
late following viral infection – after 48 h or so. 
 The polyhedrin protein forms the crystalline matrix of 
viral polyhedral bodies (also called polyhedra), whereas 
the p10 protein forms large arrays of fibrous material, 
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primarily in the nucleus but sometimes in the cytoplasm 
as well. Polyhedra formation is crucial for viral infec-
tion of insects in the wild, since they shield the delicate 
virions from harsh environmental stresses. Further, 
polyhedra act as a useful carrier of the virus particles; 
the crystalline polyhedrin matrix is solubilized in the 
mid-gut of the insect, thus releasing the virus particles 
which infect the mid-gut cells. Polyhedrin is thus an 
extremely important protein for virus survival and 
propagation in its native environment. However, under 
laboratory conditions, where growth parameters are 
tailored to suit the virus, the polyhedrin matrix is no 
longer a prerequisite for virus survival. Thus, the pol  
gene can be replaced with a heterologous gene of 
choice, which would then be efficiently expressed from 
the strong polh promoter. The same logic holds good for 
the p10 gene. The hypertranscribed polh and p10 pro-
moters are thus the workhorse promoters of the bacu-
lovirus expression vector system (BEVS). 
 The BEVS owes its popularity to many more qualiti s 
other than just the unusual strength of the polh and p10 
promoters. Some of these are described briefly below: 
Eukaryotic environment for protein production 
The BEVS provides the necessary higher eukaryotic 
environment essential for the proper folding, post-
translational modification, disulphide bond formation 
and other modifications required for the functional 
activity of many eukaryotic proteins. Post-translational 
modifications that have been reported to occur in the 
insect BEVS include signal cleavage, proteolytic cleav-
age, N-glycosylation, O-glycosylation, acylation,  
amidation, phosphorylation, prenylation and carboxy-
methylation4. All these modifications occur at sites 
identical to those in the wild type proteins, reinforcing 
the usefulness of the BEVS as one of the most favoured 
systems for expressing functionally active recombinant 
proteins. 
Extremely high levels of expression 
As mentioned earlier, the p10 and polh promoters are 
the most commonly used promoters to drive the expres-
sion of foreign genes. Being unusually strong promot-
ers, they hypertranscribe the gene(s) put under their 
control to the extent that the recombinant protein can 
account for about 25–50% of the total cellular protein. 
The polh promoter is the stronger of the two, and in-
duces higher expression levels, but investigators have 
reported protein yields of up to a gram of recombinant 
protein her litre of insect cell culture, i.e. about 109 
cells, using either promoter. Average protein yields lie 
in the range of 10– 0 mg of protein per 109 cells. In 
terms of protein yield alone, the BEVS has been ob-
served to consistently outperform other expression 
systems. The use of homologous enhancer-like se-
quences has been demonstrated to further enhance for-
eign gene expression levels several fold5. In a dition, 
live caterpillars have also been used as a host for high 
level expression, to further improve on th economics 
of expression6. 
 However, the expression kinetics differ from protein 
to protein and the promoter used7, with the time of 
expression playing a critical role in proper post-
t anslational modification and secretion8. Expression 
levels are also known to vary with the cell line used9. 
Another important parameter is the codon usage pattern 
of the recombinant gene: heterologous genes which use 
non-optimal codons of the insect host are observed to be 
po ly expressed10,11. Finally, the translation initiation 
context – as defined by the Ranjan–Hasnain consensus 
sequence11 – was also found to play a major role in 
regulating protein expression levels. Recently, a recom-
binant baculovirus carrying different B and T cell epi-
topes from nine stage-specific antigens of Plasmodium 
falciparum, has been used to express, to very high lev-
els, a recombinant multi-antigenic protein – a strong 
putative vaccine candidate for malaria12,13. 
Capa ity for large inserts and simultaneous 
ex ression 
The baculovirus nucleocapsid is predicted to be capable 
of accommodating inserts as large as 100 kb. Although 
this has not been practically tested (the largest insertion 
till date being only about 15 kb)4, no investigator has 
been hampered by the size of the heterologous gene(s) 
used for insertion. Further, a number of transfer vectors 
have been genetically engineered to simultaneously 
express multiple genes under the control of different 
viral promoters both in cell culture14–16 and in Spodop-
tera l rvae17. 
Baculovirus-mediated gene transfer into  
mammalian cells 
The BEVS has so far used only insect cells as a host for 
the expression of heterologous genes carried by recom-
binant baculoviruses. Interestingly, recent reports have 
demonstrated that they could also be used as gene de-
livery systems in mammalian cells. Although baculovi-
ruses infect over 30 species of Lepidopteran insects, 
they are incapable of replicating in other insects or in 
any of over 35 mammalian cell lines studied18,19. How-
ever, the virus does enter mammalian cells and the viral 
DNA is capable of reaching the nucleus. Experimental 
studies have shown that when an exogenous promoter, 
such as that derived from Rous sarcoma virus or cy-
tomegalovirus, is inserted into the baculovirus genome, 
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the modified virus becomes capable of gene expression 
in non-Lepidopteran cell lines, including various mam-
malian cells20,21. Boyce and coworkers20 showed that 
reporter gene expression from a recombinant baculovi-
rus was significantly higher in the human hepatocellular 
carcinoma cell line, HepG2, than in cell lines deriv d 
from other tissues like monkey kidney, human kidney, 
cervix and lung, B-cell, T-cell, rat adrenal, and mouse 
embryo fibroblast and muscle. Thus, new generation 
recombinant baculoviruses could well evolve into a 
gene delivery system of the future22. 
Safety and simplicity 
Baculoviruses are relatively simple to use. Constructing 
recombinant viruses is much faster and easier than de-
veloping stable recombinant high-expressing cell lines, 
and the host insect cells can be grown at 27°C either as 
adherent or suspension cultures. Cells can be grown in a 
BOD incubator since CO2 is not required for growth. 
Scale up has also been perfected with time, thus making 
it easy to produce large amounts of host insect cells in 
fermenters for subsequent viral infection and expression 
of recombinant proteins. Further, since baculoviruses 
have no non-arthropod hosts in vivo, they are harmless 
to humans and can be safely handled by investigators 
with no special precautions. However, a recent report 
by Gronowski et al.23, have shown that AcNPV is capa-
ble of provoking an anti-viral response in murine and 
human cell lines by inducing interferons. Although the 
possibil ty of baculoviruses infecting humans in vivo is 
remote, these findings nevertheless justify the use of 
greater precautionary measures in handling baculovi-
ruses than in the past. 
Gene expression in baculoviruses 
During an NPV infection, more than a hundred viral 
genes are expressed in a cascade that can be broadly 
divided into three stages – early, late and very late. 
Each stage is characterized by the expression of a 
unique set of genes in a well-regu ated cascade, with the 
products of one group of genes required for the expres-
sion of the next set24. By definition, early genes are 
expressed prior to viral DNA replication. Most, if not 
all, immediate-early genes encode transcriptional regu-
latory proteins25–29. DNA replication activates the viral 
template in a manner not yet defined and enables the 
late and very late classes of genes to be expressed, 
which encode proteins essential for virion assembly and 
viral occlusion formation. Although one of the most 
intriguing aspects of baculovirus biology concerns the 
control of the viral transcription cascade, we are still a 
long way from deciphering the precise mechanisms 
involved and the host and viral factors which play a role 
in this finely-orchestrated process. 
Early gene expression 
Early viral gene expression spans the time period from 
0–6 h post-infection (hpi) and results in the transcrip-
tion of genes encoding proteins required for viral DNA 
replication and late gene transcription. Most baculovi-
rus early genes have a TATA box located 25 to 30 bp
upstream of a conserved mRNA transcription initiation 
site that consists of the sequence CAGT30. The CAGT 
element, which is the firsttrue initiator element to be 
discovered in baculoviruses, has been shown to be criti-
cal for the transcription of early genes. Substitution of 
e CAGT sequence resulted in a reduction of both 
reporter activity and i  vitro transcripts, although tran-
scripts initiated accurately31. However, not all early 
genes have a CAGT and/or TATA element. A notable 
example is the dnapol gene in both BmNPV and 
AcNPV, which is observed to initiate transcription from 
a GC rich region, with no canonical TATA box or 
CAGT motif present31. Early gene expression is de-
pend nt on a a-amanitin sensitive, tagetitoxin-
insensitive host RNA polymerase II (ref. 32) and early 
gene promoters resemble typical eukaryotic class II 
p omoters. 
 Four AcNPV early genes, ie-O, ie-1, ie-2 (or ie-N), 
and pe-38, have been shown to be important for transac-
tiva ing early baculovirus promoters in transient expres-
sion assays. IE-0, IE-2, and PE-38 mRNAs are 
expressed only during the early phase of infection25,33,34. 
In contrast, IE-1 RNA is expressed during both the 
early and late phases of infection28,33. 
 IE-1, a 582-amino acid long multifunctional tran-
scriptional regulatory phosphoprotein, has been shown 
to transactivate a number of delayed-earl  genes includ-
ing 39K, ie-2 and p35 (refs 26–28) and at least one late 
gene, 39K (ref. 29). The stimulatory effect of IE-1 is 
greatest when the target promoter is cis-linked to 
AcNPV homologous repeat regions (hrs). Hr regions, 
which are present at nine dispersed locations in the 
AcNPV genome, have been shown to act as enhancers 
of transcription25,28,35–37 and also in certain cases as 
origins of viral replication38–40. However, competitive 
PCR methods used to map the activation profiles of 
AcNPV oris, have demonstrated that the ie-1 gene pro-
moter also acts as an ori, and is activated in a temporal 
fashion41. IE1 has been shown to also negatively regu-
late certain promoter regions, e.g. the promoters of the 
AcNPV ie-0 and ie-2 genes, which themselves are regu-
latory genes. Results indicate that IE1 brings about this 
downr gulation of transcription by binding directly or 
as part of a complex to IE-1 binding motifs (5¢-
ACBYGTAA-3¢) near the mRNA start site42. In addi-
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tion, it has been shown that ie-1 can activate the he-65 
gene promoter in insect Tri hoplusia ni (T. ni) 368 and 
mammalian BHK21 cells43, demonstrating that the ac-
tivity of this multifaceted protein is not confined to a 
narrow host range, but probably involves a generalized 
mechanism conserved across various species. 
 Several other baculovirus early genes also have im-
portant regulatory functions. IE-0 is a protein identical 
to IE-1 except that it has an additional 54 amino acids at 
the N terminus as a result of a splicing event33. IE-0 
mediated activation has been shown to require an hr 
enhancer44 unlike IE-1, which can regulate transcription 
in the presence or absence of a cis-linked hr sequence.  
A further difference between IE-0 and IE-1 is that the 
former does not appear to downregulate the ie-0 pro-
moter44. 
 ie-2, another early regulatory gene, both augments ie-
1 transactivation25 and brings about transcription activa-
tion independent of ie-1 (refs 26, 45). IE-2 activates the 
ie-1 promoter approximately 2.5-fold in transient ex-
pression assays45,46 and has been demonstrated to block 
cell cycle progression in a variety of cell lines, includ-
ing Sf21 and T. ni46. 
 The pe-38 gene has been shown to transactivate the 
p143 gene promoter36. Other AcNPV genes such as me-
53 and cg-30 are also thought to have some role in 
activating gene expression, based on their sequence 
similarity with transcriptional regulators from other 
systems47,48. 
 The p35 gene, an inhibitor of members of the ICE 
family of cysteine proteases and a major determinant of 
virus host range, is another ess ntial early gene. p35 is 
required to suppress the apoptotic response of S. 
frugiperda cells to AcNPV infection by acting as a 
suicide inhibitor of caspases49,50, as well as an antioxi-
dant51,52, both in Sf 21 and Sf 9 cells and S. frugiperda 
larvae49. The important role played by the p35 gene 
suggests that effective inhibition of apoptosis is re-
quired for both efficient viral DNA replication and gene 
expression53,54. 
 The early p143 gene is another important player 
in viral replication53,55, transcription, shutdown of 
host protein synthesis and viral host range determina-
tion54–56. p143 has helicase-lik  motifs, a nuclear local-
ization signal and a leucine zipper motif, is synthesized 
in virus-infected cells prior to the initiation of viral 
DNA replication and has been shown to bind non-
specifically to DNA57. In vivo complementation assays58 
revealed that some of the putative helicase motifs are 
not essential for p143 function; however, mutations 
within an ATP-binding motif, a potential helix-turn-
helix region, and certain large amino acid deletions 
inactivated protein function. Recent reports have con-
firmed that p143 is indeed a DNA helicase with ATPase 
activity59,60. LEF-3, a single-stranded DNA-binding 
protein, has been shown to interact with p143 and help 
in localizing p143 to the nucleus61. p143 is also a cru-
cial determinant of viral host range; interspecific re-
placement of a short sequence in the AcNPV p143 gene 
renders the virus capable of infecting Bombyx mori 
larvae59. It has been demonstrated that two key muta-
tions in the AcNPV p143 host specificity domain is 
enough to render the virus replication competent in Bm5 
cells, and kill B. mori larvae. 
 Finally, orf121, another baculovirus early gene has 
been observed to stimulate expression from the late 39K 
gene promoter, an activity which is dependent on ie-1 
as well62. It was later discovered that orf121 enhanced 
ie-1 expression which in turn was responsible for 
upregulating expression of the 39K gene62. 
La e and very late gene expression 
The transition between early and late viral gene expres-
sion is the most distinctive regulatory event in the bacu-
lovirus transcription/infection cascade. Whereas early 
gene expression is dependent on an a-am itin sensitive 
RNA polymerase present in uninfected cells, late and 
v ry late gene transcription involves a novel a-amanitin 
and tagetitoxin resistant, virally encoded RNA poly-
merase32,63–66. 
 The baculovirus late and very late gene promoters 
res mble mitochondrial and bacteriophage T7 late pro-
moters in that a short conserved sequence serves both as 
a promoter and an initiator element. The most con-
served sequence element of AcNPV late and very late 
promoters is the transcription initiator (A/T/G)TAAG30. 
The strength of expression from the promoters is criti-
cally dependent on the context of the TAAG sequence, 
with the 18 bp region encompassing the TAAG having 
been shown to be the minimal promoter determinant for 
basal transcription from the late vp39 promoter67. How-
ever, essential promoter determinants for the very late 
polh and p10 genes include not only the 12-bp initiator 
AATAAGTATTTT but also a downstream A + T rich 
region corresponding to the 5¢ untranslated leader se-
quence of their mRNAs68,69. This untranslated sequence 
is responsible for the ‘burst’ in transcription observed 
during very late gene expression and is thus termed the 
‘burst’ sequence. It is a defining element for very late 
gene promoters, being absent in late promoters. Muta-
tions within the burst sequence reduce expression dur-
ing the very late phase of infection by 10 to 20-fold and 
lower both the steady-state levels of polh mRNA and 
the rate of transcription initiation from the polh pro-
moter68. In contrast, mutations in sequences upstream of 
the polh promoter TAAG motif have relatively milder 
effects on polh gene expression69. Progressive deletions 
of the p10 promoter also suggest the presence of a burst 
sequence that is essential for strong expression during 
the v ry late phase69. 
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 The AcNPV very late factor 1 (vlf-1) gene has been 
shown recently to play an important role in very late 
gene expression from the polh and p10 gene promoters. 
vlf-1, a late gene, was originally identified by charac-
terization of an occlusion-defective mutan  virus, 
tsB837, which produced extremely low levels of polh 
and p10 transcripts during the very late phase of infec-
tion. In transient expression assays, vlf-1 was shown to 
stimulate expression from very late promoters but not 
from late promoters70, making it probably the only well 
characterized viral factor known to date that regulates 
only very late but not late gene expression. Interest-
ingly, recombinant baculoviruses with altered vlf-1 
expression revealed that the time of vlf-1 expression 
and/or the concentration of VLF-1 in the cell was criti-
cal for switching on the polhand p10 genes71,72. Recent 
studies have revealed that the VLF-1 protein binds 
directly to the untranslated regions of the polh and p10 
promoters and is closely correlated with their transacti-
vation73. Thus, VLF-1 seems to be a crucial player  
in the regulation of baculovirus very late gene expres-
sion. 
 Until recently, eighteen AcNPV genes, called lefs 
(late expression factors), were identified74–77 which are 
necessary to support transient expression of a reporter 
gene under the control of the late vp39 promoter. The 
same set of lefs has also been shown to be involved in 
transient expression of the late basic 6.9-kDa protein 
gene70 and the very late polh68 and p10 genes70. All 
these genes have been shown to affect steady state lev-
els to reporter gene transcripts, implying that their ef-
fect is mainly at the transcriptional and not at the 
translational level54. 
 Nine of the 18 genes (i -1, ie-2, lef-1, lef-2, lef-3, 
lef7, p143 (also called nahel), dnapol, and p35) are 
necesary and sufficient for supporting replication of a 
plasmid containing a viral origin of replication54. 
Hence, they may act indirectly, by supporting viral 
DNA replication post-infection, which is also essential 
for late and very late gene expression. 
 The ie-1 and ie-2 genes, as explained above, are im-
portant immediate early genes which regulate the ex-
pression of their own genes and other immediate – and 
delayed early genes in the viral cascade. p143 (dnahel) 
and dnapol encode polypeptides with sequence similar-
ity to DNA helicases and polymerases, respectively, 
suggestive of their role in viral DNA replication. The 
viral late expression factor 3 (lef-3) gene product has 
been shown to have single-stranded DNA binding activ-
ity78. LEF-3 forms a homotrimer in solution79 and helps 
to localize the P143 DNA helicase to the nucleus61. Th  
BmNPV LEF-3 protein has been demonstrated to have a 
helix-destabilizing activity, which may act in concert 
with P143 to facilitate strand separation during DNA 
replication. The involvement of p35, a known inhibitor 
of apoptosis, suggests that the apoptotic pathway needs 
to be blocked in order for DNA replication and subse-
quent transcription to occur. 
 The lef-1, lef-2 and lef-7 genes have been shown to be 
essential for DNA replication. The LEF-1 protein has 
primase-like motifs, which when mutated abrogates the 
ability of LEF-1 to support transient DNA replication80. 
Furthermore, two-hybrid screens have d monstrated, 
although the exact mechanism is unclear, that LEF-1 
and LEF-2 interact with each other, and probably func-
tion synergistically in the replication process80. Th  lef-
2 gen  also plays an important role in replication56. 
M rrington and coworkers81 identified a mutant virus, 
VLD1 which was defective in late and very late gene 
expression which was subsequently found to be the 
result of a point mutation in the lef-2 gene. Interest-
ingly, the virus was not defective in DNA replication, 
suggesting that lef-2 may play a dual role, both in DNA 
replication and very late gene expression, with different 
domains of the protein required for different functional 
roles81. The lef-7 gene has been demonstrated not to be 
absolutely essential for DNA replication, but instead 
have a stimulatory effect. l f-7, like lef-3, is dependent 
on the multifunctional trans-regulatory gene, i -1, for 
its activity in transient expression assays75. 
 The remaining 9 lefs, i.e. lef-4, lef-5, lef-6, lef8, lef-9, 
lef-10, lef-11, 39K and p47 are directly involved in 
regulating late and very late gene expression, and not 
simply as a consequence of supporting DNA replica-
tion. 
 The 39K gene encodes a phosphoprotein, pp31, which 
associates with the virogenic stroma, a virus-induced 
nuclear structure which appears to be the site for nu-
cleocapsid assembly82. 39K, like several other genes, is 
also regulated by the transactivator IE-1. ORF121 and 
IE-2 also upregulate expression of 39K, although this 
was found to be by virtue of their en anc ment of IE-1 
expression62. P35 also enhances expression of 39K by a 
mechanism which is thought to be different from that 
adopted by ORF 121, IE2 and IE-1 (ref. 62). 
 Recently, the virus-specific RNA polymerase was 
purified63 and was apparently found to be composed of 
equimolar subunits of 4 lefs: LEF-4, LEF-8, LEF-9, and 
p47. LEF-8 and LEF-9 were earlier described as having 
some, though not extensive, sequence similarity with 
other DNA-dependent RNA polymerases74,77. This po-
lymerase has been suggested to be the simplest DNA-
dir cted RNA polymerase reported till date from any 
eukaryotic source. The polymerase supported transcrip-
tion from late and very late promoters but wa  not ac-
tive on early promoters. Interestingly, both late and 
very late promoters were transcribed with equal effi-
cienty, highlighting the fact that the polymerase lacked 
the factors to bring about temporal expression of the 
late and very late genes in the sequential order required 
during the viral cascade of infection. Significantly, this 
complex of 4 equimolar subunits has not been shown to 
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function in in vitro reconstitution experiments but has 
been demonstrated to act only within the insect cell 
environment. The role of other host factor(s) in this 
process, in vivo, has thus not been excluded. 
 The LEF-4 protein was recently shown to have 
guanylyltransferase activity. It could hydrolyse the 
gamma-terminal phosphate of the 3¢ end of RNA and 
also ATP and GTP to their respective dinucleotide 
forms83. These activities and the fact that LEF-4 has a 
KXDG motif, and homology with motifs common to 
viral and cellular guanylyltransferases, suggest that it 
may be part of a baculovirus RNA-capping complex. 
The triphosphatase, guanylyltransferse and methyltrans-
ferase components of the capping apparatus are organ-
ized differently in metazoan, viral and fungal systems. 
However, vaccinia virus capping enzyme has been 
shown to combine all three properties in a single multi-
functional protein. LEF-4 combines the first two func-
tions of the capping apparatus and is thus thought to  
be the major player in baculoviral mRNA capping83 
besides being part of the core RNA polymerase com-
plex. 
 Of the remaining constituents of the viral RNA poly-
merase, the LEF-8 and LEF-9 proteins are hypothesized 
to constitute the catalytic core of the RNA polymerase 
since they possess amino acid sequence motifs with 
homology to other polymerases63. However this has not 
been proved experimentally, and the role of the p47 
protein is still unknown. 
 No information is currently available on the functions 
of lef-6, lef-10 and lef-11 and the mechanism by which 
they are involved in late and very late gene expression. 
Although the exact role of f-5 too has not been deline-
ated, it has been recently reported that the C-terminal 
end of the protein contains  novel domain which is 
homologous to the zinc ribbon domain of RNA poly-
merase elongation factor IIS (TFIIS) from a variety of 
taxa84. The same report also documents the interaction 
of the LEF-5 protein with itself and suggests that LEF-5 
may be involved in transcript elongation. 
 Apart from these 18 lefs, a new factor, lef 12, has 
been identified of late, which is also supposed to be 
essential for late and very late gene transcription85. A 
set of plasmids was constructed in which each of the 18 
lef open reading frames (ORFs) was controlled by the 
Drosophila melanogaster h at shock protein 70 (hsp70) 
promoter and epitope tagged. However, this set  
of plasmids failed to support transient late gene expres-
sion. The inability of the p47 ORF to replace the  
p47-containing plasmid supplied in the lef plasmid 
library led to the identification of a 19th late expression 
factor gene (lef-12) located adjacent to the p47 
gene. The sequence of lef-12 is predicted to encode a 
21 kDa protein with no homology to any previously 
identified protein. The function of le -12 is yet to be 
elucidated. 
Role of host factors in very late gene expression 
All of the factors with an established role so far in viral 
late and very late gene expression, including the polh 
and p10 genes, are viral proteins. However, many insect
cell host factors too are critically important for this 
process. Our laboratory has been working on this aspect 
f r the past several years and has identified several 
cellular proteins which play a crucial role in very late 
gene expression, using the pol  promoter as a model86. 
 Etkin and coworkers87 had earlier identified a 
200 kDa protein present in Sf9 cells which binds to the 
polh promoter and was implicated in negative regula-
tion of the promoter. However, the functional impor-
tance of this putative factor was not elucidated and 
ther  were no further reports about it thereafter. 
 The first host protein to be clearly identified as hav-
ing an authentic role in polh transformation is the un-
usual 30-kDa transcription factor, the polh promoter 
b ding protein (PPBP) identified in our laboratory88,89. 
This phosphoprotein binds with very high affinity
and specificity to a hexanucleotide sequence motif, 
AATAAA, present within the minimal promoter imme-
diately 5¢ to the octanucleotide motif TAAGTATT 
which encompasses the transcription start point90. PPBP 
probably acts as an initiator binding protein (IBP) in-
volved in the recruitment of the transcription machin-
ery. PPBP specifically binds to the coding strand of the 
promoter91 with increased affinity, compared to the 
duplex promoter, thus maintaining the promoter at the 
nitiation point in a ‘melted’ state and allowing for 
increased rounds of transcription. Sequestering PPBP 
using its cognate binding motif – the polh promoter B 
domain – resulted in a drastic reduction in transcription 
 
 
 
 
Figure 1. PPBP is required for transcription from the polh pro-
moter. In vitro transcription from Ppolh was carried out using a C-
free template plasmid. Transcription was reduced drastically when 
PPBP was titrated out using its cognate binding motif (compare lanes 
3 and 2) and restored when the reaction was replenished with Sf9 
nuclear extract containing PPBP (lane 4). Lane 1 is a control reaction 
carried out in the absence of template DNA. 
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Figure 2. PPBP also binds to the p10gene promoter. EMSA show-
ing a PPBP–DNA complex using the p10 B domain promoter se-
quence as probe. The complex (lane 2) could be specifically 
competed out using either the cold p10 or p29 (polh) promoter 
sequences (lanes 3 and 4, respectively) but not by polh promoter 
oligonucleotides carrying mutations in the TAAGTATT (mO) or 
AATAAA (mH) motifs (lanes 5 and 6, respectively). pUC18 DNA, 
used as a non-specific competitor, did not compete for binding either 
(lane 7). Lane 1 represents the free probe. 
in vitro and in vivo90 (Figure 1). Interestingly, PPBP has 
been shown to interact with the transcriptionally impor-
tant AATAAA and TAAGTATT motifs of the p10 pro-
moter also92 (Figure 2), suggesting that it may have a 
role in the regulation of gene expression from very late 
promoters in general (Jain, A., Ph D thesis). 
 The second host factor identified in our laboratory is 
the 38 kDa homologous region-1 (hr1) binding protein 
(hrBP), which binds at multiple sites within the AcNPV 
hr1 enhancer element, with high specificity and affin-
ity37. There are nine homologous regions quences (hrs) 
dispersed throughout the AcNPV genome, viz. hr1, 
hr1a, hr2, hr2a, hr3, hr4a, hr4b, hr4c and hr5 (refs 93, 
94), which act as origins of replication (oris) as well as 
enhancers of transcription for some baculovirus early 
and late genes. Our laboratory has shown that the hr1 
enhancer enhances transcription from the p lh promoter 
and also act as a putative or , with both functions hav-
ing distinct sequence requirements40. The 750 bp hr1 
sequence element contains 5 imperfect palindromes 
with an EcoRI site at the centre of each palindrome. An 
intact palindrome along with the flanking sequence is 
the minimal requirement for the enhancer function of 
h 1 (Figure 3, ref. 40). This is in contrast to its replica-
tion function, where a palindrome alone was found to be 
both necessary and sufficient for the ori function of hr1 
in transfected cells40. Hr1BP requires phosphorylation 
 
 
 
 
 
Figure 3 a. Enhancement of luciferase expression is a function of hr1 modules. Schematic representation of 
plasmid constructs carrying different components of hr1 used for analysis in transient expression a says. 
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Figure 3 b. Enhancement of luciferase expression is a function of 
hr1 modules. Luciferase activity from these constructs represented as 
fold-enhancement over pSHluc (L). The different hr reporter con-
structs are indicated. 
 
 
 
 
Figure 4. Hr1BP is required for the enhancer function of hr1. 
Luciferase expression of hr1-containing constructs (pSHluc-hrU1, 
U1) co-transfected with varying amounts of competitor plasmid (C, 
pSH-hrU1) carrying the hr1 sequence (bars 3–7). Bars, 4, 5, 6, and 7, 
corresponding to 1, 5, 10, and 20 mg of competitor plasmid respec-
tively, show a drop in luciferase expression relative to bar 3, which 
has no competitor. Bars 1 and 2 are controls showing that there is no 
effect on luc expression with (lane 2) or without (lane 1) competitor 
in the case of a reporter plasmid which carries no hr1 sequence (L, 
pSHluc). 
 
for binding and is essential for the enhancer function of 
hr1, as demonstrated by in vivo competition experi-
ments37 (Figure 4). 
 The host factor PPBP, which binds to the polh pro-
moter and probably helps recruit the RNA polymerase90, 
specifically recognizes the transcriptionally important 
AATAAA and TAAGTATT motifs within the polh 
promoter. Promoter vector constructs (Figure 5, ref. 95) 
were made, where the AATAAA was mutated to 
CCCCCC and the mutant promoter used to drive tran-
scription of a downstream luciferase reporter gene. It 
was expected that reporter gene expression would be 
drastically affected, if not reduced to zero. Surprisingly, 
however, the drop in luciferase reporter expression 
(Figure 5, ref. 95) from the mutant promoter construct 
vis-à-vis the wild type promoter was not as sharp as 
expected. On closer analysis, it was apparent that an 
~ 766 bp stretch present upstream of Ppolh could com-
pensate for mutations within the promoter. When a 
control plasmid containing the mutant promoter with no 
upstream regions was analysed, it showed almost no 
luciferase expression, underscoring the importance of 
upstream sequences in the regulation of Ppolh. In a 
separate experiment, Bal31 deletion analyses of a 4 kb 
region upstream of the polh promoter identified two 
transcriptionally important regions, region I and region 
II (containing the 766 bp upstream sequence), spanning 
map units 0 to 1.5 and 2.5 to 3.12 respectively on the 
EcoRI ‘I’ fragment of the viral genome (Ch. Anser 
Azim, unpublished data). The deletion of these  
regions resulted in a significant reduction in polh pro-
moter-driven reporter gene expression. These findings, 
coupled with the ‘promoter-knockout’ analysis results 
described above, promoted a more detailed dissection of 
region II. 
The Sp family of proteins 
A careful analysis of region II revealed a sequence 
motif, which we termed AcSp (for Aut grapha califor-
nica nuclear polyhedrosis virus Sp-like sequence), 
which carried GC and GT box-like motifs which are 
known to be bound by the Sp family of proteins (Figure 
6). Keeping in mind the functional significance of the 
upstream sequences and the fact that Sp-family roteins 
have so far not been demonstrated in insect cells, it was 
pertinent to explore this region further to determine the 
importance, if any, of the AcSp sequence notif and any 
trans-acting factors that may bind to it. It was observed 
that AcSp and the consensus Sp1 sequence (cSp) sp-
cifically bound factor(s) in HeLa and Spodoptera 
frug perda (Sf9) insect cell nuclear extracts to generate 
identical binding patterns, indicating the similar nature 
of the factor(s) interacting with these sequences. Re-
combinant plasmid constructs carrying the AcSp and 
cSp oligonucleotides enhanced i  vivo expression of a 
polh promoter-d iven luciferase gene (Figure 7). In vivo
mopping of these factor(s) significantly reduced tran-
scription from the polh promoter (Figure 8, ref. 95), and 
recombinant viruses carrying deletions in the upstream 
sequences containing AcSp confirmed the requirement 
of hese factor(s) in polh promoter-driv n transcription 
in the viral context (Figure 9, ref. 95). Our results thus 
document, for the first time, DNA–protein interactions 
involving novel members of the Sp-family of proteins in 
adult insect cells and their involvement in transcription 
from the polh promoter95. 
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Figure 5. A ~ 766 bp region (containing the ORF603) can compensate for mutations within Ppolh. 
pAJpBS603-luc contains the wild type Ppolh driving expression of a luciferase reporter, with a ~ 766 bp up-
stream region. PAJpBS603mH-luc and pAJmHluc are the corresponding plasmids carrying a mutated pro-
moter, with and without the 766 bp region, respectively. The corresponding luciferase values are shown 
alongside. 
 
 
 
Figure 6. An Sp-like binding sequence (AcSp) is present upstream of Ppolh. The AcSp sequence bears a 
consensus CACCC motif and a loose GC box, depicted in boldface, on the non-coding strand. 
 
 
 One of the most common regulatory elements present 
in eukaryotic promoters, enhancers and locus control 
regions is the GC box (GGGCGG), or the related 
GT(GGGTGG)/CACCC boxes. The first major advance 
in our understanding of how these sequences contribute 
to the control of gene expression was the isolation and 
identification of the GC-box binding protein, Sp1. As it 
turned out, Sp1 is simply the first cloned and identified 
member of a large and still growing family of proteins 
which bind to similar GC/GT box sequences and share a 
highly conserved DNA-binding zinc finger domain96,97. 
Th  superfamily is referred to as the Sp or XKLF 
(Krüppel- ike factor) family, since the zinc finger DNA 
binding domains of all the members share homology 
with those found in the Drosophila melanogaster regu-
lator protein Krüppel97. Currently, the Sp/XKLF family 
comprises at least 16 different mammalian family me-
bers, and is rapidly expanding. Although some Sp-like
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Figure 7. The AcSp and cSp sequence motifs enhance reporter gene expression when placed upstream to the 
polyhedrin promoter. Luciferase activity in transient expression analyses using pAcSp.pol.luc and 
pcSp.pol.luc, carrying the AcSp and cSp oligonucleotides respectively, upstream of the polh promoter. The 
relative luciferase levels of pcSp.pol.luc and pAcSp.pol.luc were compared with those of pAJpolluc (with no 
upstream sequences) and pKN603luc (carrying ~ 4 kb upstream sequences). 
 
 
 
 
 
Figure 8. Mopping of the insect Sp-family protein(s) in vivo causes a reduction in polh promoter-driven re-
porter gene expression. Luciferase expression levels using 20 mg of pAcSp.pol.luc (lane 7) and pcSp.pol.luc 
(lane 8) plasmids after transfection into Sf9 cells were compared in the presence of specific or non-specific co-
transfected competitor plasmids. Lanes 1 and 4 show luciferase expression using the reporter plasmids 
pAcSp.pol.luc and pcSp.pol.luc respectively, with pUC19 used as a non-specific c mpetitor. Lanes 2 and 3 
depict luciferase expression using pAcSp.pol.luc in the presence of competitor plasmids pAR1 or pAR2 re-
spectively. Likewise, the competition with pAR1 or pAR2 using pcSp.pol.luc as reporter is shown in lanes 5 
and 6 respectively. Lane 9 depicts AcNPV infection carried out in the absence of any transfec ed plasmid. 
pAR1 and pAR2 plasmids carry the AcSp and cSp oligonucleotides respectively, cloned into pUC19. 
 
 
proteins have been identified in Drosophila embryos 
only during the blastoderm stage, there are no reports of 
such factors being present in adult insect tissue. 
 Our findings show both an enhancement (in the case 
of an intact promoter) and a rescue of transcription (in 
the presence of a mutant promoter) with Ppolh upstream
SPECIAL SECTION: SCIENCE IN THE THIRD WORLD 
 
CURRENT SCIENCE, VOL. 81, NO. 8, 25 OCTOBER 2001 1008
 
Figure 9 a. AcSp is required for enhancement of transcription from the polh promoter in the viral context. 
Schematic representation of the recombinant baculoviruses vMAluc, vDluc and vAcSpluc carrying the poly-
hedrin promoter-driven luciferase gene, with varying sizes of upstream sequences. 
 
 
Figure 9 b. AcSp is required for enhancement of transcription from 
the polh promoter in the viral context. Luciferase levels recorded in 
Sf 9 cells, or after infection with AcNPV or recombinant viruses, 
assayed 65 hpi. 
 
 
Figure 10. Regulation of transcription from the AcNPV polyhedrin 
promoter. The hypertranscribed polh promoter recruits viral as well 
as insect cell host factors to enhance transcription. PPBP, which 
recruits the viral RNA polymerase to the transcription initiation site, 
Sp family-like proteins which bind to a promoter-proximal cis-
sequence, and hr1BP, which interacts with the powerful upstream hr1 
enhancer element play critical roles in this process. 
regions carrying the AcSp or cSp motifs. Sp1 has been 
found to activate transcription from both TATA – and 
Inr – (initiator element) containing promoters. Further, 
in the bovine papillomavirus E2-responsive promoters, 
the TATA box or the initiator can be functionally re-
placed by Sp1 binding sites98. These data provided the 
first suggestion of an interaction between Sp1 and the 
general transcription machinery, particularly TFIID. 
Consistent with this observation, it was subsequently 
demonstrated that the human TBP-associated factor, 
hTAFII130 (ref. 99), and its Drosophila homolog, dTA-
FII110 (ref. 100), interact with the glutamine-r ch acti-
vation domains of human Sp1. Thus, Sp1 is thought to 
function by recruiting the RNA polymerase complex to 
promoters via its interaction with TFIID. The most 
obvious explanation of the enhancement of reporter 
gene expression by the insect Sp family-like protein(s) 
is that they interact with the basal transcription machin-
ery directly or indirectly to bring about these effects. 
Electromobility shift assays using the consensus TFIID 
oligonucleotide point to a possible interaction between 
the insect SP-like proteins and TFIID, hinting at a simi-
lar mode of action in Sf 9 cells too (Ramachandran, A., 
unpublished observations). 
Conclusion 
Intensive research has gone into the elucidation of the 
mechanisms underlying baculovirus transcriptio  regu-
lation. However, the ways of the powerful BEVS re-
main as enigmatic as ever. An understanding of all the 
players involved in this process would allow us to re-
create in vitro the conditions and factors governing polh 
or p10 promoters transcription, hus permitting the 
synthesis of foreign proteins to the desired extent while 
by-passing laborious tissue culture or in vivo systems. 
 In this context, host factors have emerged as a crucial 
component involved in regulating transcription from the 
baculovirus very late promoters. In addition to PPBP, 
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and hrBP, our observations on the presence and i-
volvement of Sp family-like host factor(s) in insect 
cells is novel. Their involvement in the regulation of a 
gene so critical for baculovirus survival in the environ-
ment adds an important dimension to the complexity 
of polh promoter-driven transcription. Given that  
the polh promoter is a TATA-less initiator promoter, 
coupled with the known involvement of Sp1 in initiator-
mediated transcription, these results r veal another  
facet of the regulation of polyhedrin-initiator transcrip-
tion. 
 Studies are in progress to further characterize the Sp-
like factor(s) which bind to AcSp and elucidate in 
greater detail the transcription mechanisms by which 
they operate. A model of the major trans-acting fac-
tor(s) influencing transcription from the polh promoter 
(Figure 10) thus involves an interplay of host and viral 
factors. Coupled with structural information and knowl-
edge of the Sp protein(s) and other host factors’ cross-
talk with various cellular or viral partners, we can ex-
pect more pieces of the complex and fascinating jigsaw 
puzzle of baculovirus gene regulation to fall into place 
in the near future. 
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